The inhibitory effect of auraptene on cell growth as well as reduced expression and activity of the androgen receptor (AR), a key driver of prostate cancer progression, raise the possibility of auraptene, a major component of Citrus hassaku, being useful as a treatment for or protection against the development of prostate cancer. Here, AR is linked to prostate carcinoma.